Kevin Wayne Baszis MD RhMSUS
Juvenile Rheumatoid Arthritis and Related Rheumatology, Pediatric Lupus and Related Rheumatology, Pediatric Vasculitis Rheumatology
Associate Professor, Pediatrics, Washington University School of Medicine
Dr. Baszis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kevin Baszis is a Pediatric Rheumatologist based in Saint Louis, MO, treating patients with Juvenile Idiopathic Arthritis, Lupus, MCTD, Sjogren syndrome, Vasculitis, autoinflammatory syndromes, among others. He is a graduate of the University of Missouri Kansas City School of Medicine (class of 2004) and has completed his Fellowship and Residency in Pediatric Rheumatology and Pediatrics respectively at Washington University/B-JH/SLCH Consortium, where he served as the Chief Resident. Dr. Baszis is currently an Associate Professor of Pediatrics at Wash U School of Medicine. His multiple publications in pediatric rheumatology include works on dermatomyositis and systemic juvenile idiopathic arthritis, amongst others.
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Pediatric Rheumatology, 2008 - 2011
- Washington University/B-JH/SLCH ConsortiumChief Residency, Pediatrics, 2007 - 2008
- Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics, 2004 - 2007
- University of Missouri Kansas City School of MedicineClass of 2004
Certifications & Licensure
- AR State Medical License 2021 - 2026
- IL State Medical License 2018 - 2026
- MO State Medical License 2007 - 2026
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Rheumatology
- American College of RheumatologyRhMSUS Musculoskeletal Ultrasound Certification
Publications & Presentations
PubMed
- Efficacy and safety of ibuprofen and naproxen in the treatment of oligoarticular juvenile idiopathic arthritis: bi-national cohort study.Orly Ohana, Itay Marmor, Rina Ferguson, Yoel Levinsky, Shiri Rubin
Immunopharmacology and Immunotoxicology. 2025-04-01 - Approaches and outcomes of adalimumab discontinuation in patients with well-controlled inflammatory arthritis: a systematic search and review.Erin Balay-Dustrude, Jessica Fennell, Kevin Baszis, Y Ingrid Goh, Daniel B Horton
Pediatric Rheumatology Online Journal. 2024-12-30 - 1 citationsInterleukin (IL)-1/IL-6-Inhibitor-Associated Drug Reaction With Eosinophilia and Systemic Symptoms (DReSS) in Systemic Inflammatory Illnesses.Vivian E Saper, Lu Tian, Ruud H J Verstegen, Carol K Conrad, Michal Cidon
The Journal of Allergy and Clinical Immunology. in Practice. 2024-11-01
Authored Content
- Exploring the Vexing Intersection of Lung Disease in Pediatric Rheumatology at #ACR19November 2019
- Exploring the Vexing Intersection of Lung Disease in Pediatric Rheumatology at #ACR19November 2019
Professional Memberships
- Member
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: